Prosecution Insights
Last updated: April 19, 2026

Kezar Life Sciences

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18019885 PROTEIN SECRETION INHIBITORS BELL, SARA ELIZABETH 1625 Non-Final OA Feb 06, 2023
17434029 PROTEIN SECRETION INHIBITORS CHICKS, ASHLI ARIANA 1626 Final Rejection Aug 26, 2021

Managing Kezar Life Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month